Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 486 participants.
Also called NCT01101009
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 486 participants
- Registry
-
NCT01101009 -
2009-012966-30
-
- Other papers using this trial's data
- The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT01101009. Randomized; double masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2012-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure
- Condition
- Hypertension
- Intervention (Drug)
- Perindopril + amlodipine + if necessary, hydrochlorothiazide
- Intervention (Drug)
- olmesartan/amlodipine + hydrochlorothiazide, if necessary.
- Lead sponsor
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Record details
- Record id
cardio:ct-nct01101009- Content hash
9f9e987d61591e8f5184e0f77ef9f03a9be7b998219c7584fb0db4bb2f2d5143